Head and neck manifestations of the immune reconstitution syndrome in HIV-infected patients: a cohort study

Otolaryngol Head Neck Surg. 2012 Jul;147(1):52-6. doi: 10.1177/0194599812437321. Epub 2012 Feb 15.

Abstract

Objective: To describe head and neck manifestations of immune reconstitution inflammatory syndrome (IRIS) in a cohort of HIV-infected patients receiving combined antiretroviral therapy (cART). After initiation of cART, some HIV-infected patients present a paradoxical worsening and clinical deterioration due to pathological inflammatory reactions to infectious or noninfectious antigens, a condition known as IRIS.

Study design: Prospective study with a follow-up period of 6 to 24 months.

Setting: Tertiary referral center in Mexico City.

Methods: Our cohort was integrated by 165 patients who had started cART within the past 2 months prior to study entry. Patients underwent a complete ear, nose, and throat examination (ENT). Laboratory tests (hematology and blood chemistry), cultures from body fluids, and biopsies were performed.

Results: Of the 165 patients studied, 21 (12.7%) presented IRIS in the head and neck region. Kaposi sarcoma was the most common presentation, observed in 7 patients. Tuberculosis-associated IRIS was observed in 6 patients with scrophulas, lymph node enlargement, or retropharyngeal abscess. Other manifestations included herpes simplex I infection and unilateral vocal fold palsy secondary to Mycobacterium avium intracelulare paratracheal abscess and scrophulas, as well as cervical lymph node histoplasmosis and facial palsy.

Conclusions: To our knowledge, this is the first prospective study describing the different manifestations of IRIS in the head and neck region.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cohort Studies
  • Female
  • HIV Infections / complications*
  • Head and Neck Neoplasms / etiology*
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / complications*
  • Male
  • Otorhinolaryngologic Diseases / etiology*
  • Prospective Studies
  • Sarcoma, Kaposi / etiology*
  • Tuberculosis / etiology*